文献速递遗传性与小管间质肾病慢性肾脏病

一种简化MUC1变异检测的新型简便经济分子检测方法

Description of a New Simple and Cost-Effective Molecular Testing That Could Simplify MUC1 Variant Detection.
PubMed 文献 · Kidney Int Rep · 2024-02-03

该研究开发了一种生物信息学计数脚本,用于检测MUC1特定基因序列并计数,采用27例患者DNA样本验证,与BROAD研究所参考技术确认100%一致,临床特征与既往ADTKD-MUC1描述相似。

要点

  • 新型计数脚本可检测MUC1变异,与参考技术100%一致。
  • ADTKD-MUC1临床表现非特异,易漏诊。
  • 提高MUC1诊断可及性有助于疾病理解和特异性治疗开发。

核心结论

  • 描述了一种简便经济的ADTKD-MUC1分子检测方法。
  • 队列遗传分析提示MUC1可能是ADTKD的首位病因。

研究设计与样本

  • 研究开发了生物信息学计数脚本,检测特定遗传序列并计数。
  • 使用27例患者DNA样本验证,其中11例来自法国里尔大学医院,16例来自美国北卡罗来纳州维克森林医院。
  • 里尔患者使用NGS基因面板结合脚本检测,维克森林患者使用快照参考技术检测。
  • 2018年1月至2023年2月收集所有经脚本诊断MUC1变异患者的数据。

主要发现

  • 27例样本经BROAD研究所参考技术匿名确认,MUC1诊断一致率为100%。
  • 队列的临床生物学特征与既往ADTKD-MUC1描述相似。

临床怎么用

  • 该脚本可整合至NGS流程,简化MUC1变异检测。
  • 提高MUC1诊断可及性,有助于识别ADTKD-MUC1患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with autosomal dominant tubulointerstitial kidney disease (ADTKD) usually present with nonspecific progressive chronic kidney disease (CKD) with mild to negative proteinuria and a family history. ADTKD-MUC1 leads to the formation of a frameshift protein that accumulates in the cytoplasm, leading to tubulointerstitial damage. ADTKD-MUC1 prevalence remains unclear because MUC1 variants are not routinely detected by standard next-generation sequencing (NGS) techniques. METHODS: We developed a bioinformatic counting script that can detect specific genetic sequences and count the number of occurrences. We used DNA samples from 27 patients for validation, 11 of them were patients from the Lille University Hospital in France and 16 were from the Wake Forest Hospital, NC. All patients from Lille were tested with an NGS gene panel with our script and all patients from Wake Forest Hospital were tested with the snapshot reference technique. Between January 2018 and February 2023, we collected data on all patients diagnosed with MUC1 variants with this script. RESULTS: A total of 27 samples were tested anonymously by the BROAD Institute reference technique for confirmation and we were able to get a 100% concordance for MUC1 diagnosis. Clinico-biologic characteristics in our cohort were similar to those previously described in ADTKD-MUC1. CONCLUSION: We describe a new simple and cost-effective method for molecular testing of ADTKD-MUC1. Genetic analyses in our cohort suggest that MUC1 might be the first cause of ADTKD. Increasing the availability of MUC1 diagnosis tools will contribute to a better understanding of the disease and to the development of specific treatments.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Fages V, Bourre F, Larrue R, et al. Description of a New Simple and Cost-Effective Molecular Testing That Could Simplify MUC1 Variant Detection. Kidney Int Rep. 2024. PMID: 38707821. doi:10.1016/j.ekir.2024.01.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。